Slow Release Morphine Did Not Reduce Neonatal Abstinence Syndrome More Than Methadone

Evidence-Based Mental Health - United Kingdom
doi 10.1136/ebmh.2.4.109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Morphine vs Methadone in the Treatment of Neonatal Abstinence Syndrome

Acta Paediatrica, International Journal of Paediatrics
MedicineChild HealthPediatricsPerinatology
2019English

Slow Release Oral Morphine Versus Methadone for the Treatment of Opioid Use Disorder

BMJ Open
Medicine
2019English

Predicting Length of Treatment for Neonatal Abstinence Syndrome in Methadone-Exposed Neonates

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2008English

Neonatal Abstinence Syndrome

Clinical Obstetrics and Gynecology
GynecologyObstetrics
2013English

Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study

Journal of Pediatrics
Child HealthPediatricsPerinatology
2015English

Phenobarbital Versus Morphine in the Management of Neonatal Abstinence Syndrome, a Randomized Control Trial

BMC Pediatrics
Child HealthPediatricsPerinatology
2015English

OxyContin and Neonatal Abstinence Syndrome

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2002English

Neonatal Abstinence Syndrome and Criminal Liability

Turkish Journal of Forensic Medicine
2017English

Can Methadone Concentrations Predict the Severity of Withdrawal in Infants at Risk of Neonatal Abstinence Syndrome?

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy